Warning
IntegraDose Compounding Services LLC Recalls Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0593-2026Drug / Pharmaceutical
IntegraDose Compounding Services LLC Recalls Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride
IntegraDose Compounding Services LLC · Class II — Moderate Risk
Product Description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Reason for Recall
Subpotent Drug
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S.A. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from IntegraDose Compounding Services LLC, initiated on May 18, 2026. Subpotent Drug. This recall covers 287 units, distributed in U.S.A. Nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.